The Effectiveness of Pharmacist Interventions on Cardiovascular Risk: The Multicenter Randomized Controlled RxEACH Trial

• Published in: Journal of the American College of Cardiology Vol. 67; no. 24; pp. 2846 - 2854
• Main Authors: Tsuyuki, Ross T, Al Hamarneh, Yazid N, Jones, Charlotte A, Hemmelgarn, Brenda R
• Format: Journal Article
• Language: English
• Published: United States Elsevier Limited 21.06.2016
• Subjects: Acute coronary syndromes; Alberta - epidemiology; Cardiology; Cardiovascular disease; Cardiovascular Diseases - prevention & control; Cholesterol; Cholesterol, LDL - blood; Community Pharmacy Services; Confidence intervals; Continuity of Patient Care; Coronary vessels; Diabetes; Diabetes Mellitus - blood; Diabetes Mellitus - epidemiology; Diabetes Mellitus - therapy; Disease prevention; Drug stores; Dyslipidemias - blood; Dyslipidemias - epidemiology; Dyslipidemias - therapy; Family medical history; Female; Glycated Hemoglobin A - analysis; Health risk assessment; Heart attacks; Humans; Hypertension; Hypertension - epidemiology; Hypertension - therapy; Intervention; Laboratories; Male; Medication Reconciliation; Middle Aged; Patient Education as Topic; Pharmacists; Risk Assessment; Risk factors; Smoking; Smoking - adverse effects; Smoking - epidemiology; Smoking Cessation - statistics & numerical data; Alberta Canada; Canada; United States > US; blood pressure; dyslipidemia; diabetes; smoking

Despite the cardiovascular disease (CVD) risk associated with hypertension, diabetes, dyslipidemia, and smoking, these risk factors remain poorly identified and controlled. The study sought to evaluate the effectiveness of a community pharmacy-based case finding and intervention on cardiovascular ri...